Citation: | LI Jinmei, SONG Hui, LIAN Qihui, CHEN Minji, ZHANG Liang, XIE Wei. Chemoresistance of negative costimulatory molecule B7-H4 to 786-O cells[J]. Journal of China Pharmaceutical University, 2013, 44(6): 553-558. DOI: 10.11665/j.issn.1000-5048.20130613 |
[1] |
Sica GL,Choi IH,Zhu G,et al.B7-H4,a molecule of the B7 family,negatively regulates T cell immunity[J].Immunity,2003,18(6):849-861.
|
[2] |
Prasad DV,Richards S,Mai XM,et al.B7S1 a novel B7 family member that negatively regulates T cell activation[J].Immunity,2003,18(6):863-873.
|
[3] |
Zang X,Loke P,Kim J,et al.B7x:a widely expressed B7 family member that inhibits T cell activation[J].Proc Natl Acad Sci U S A,2003,100(18):10 388-10 392.
|
[4] |
Ceeraz S,Nowak EC,Noelle RJ.B7 family checkpoint regulators in immune regulation and disease[J].Trends Immunol,2013,doi: 10.1016/j.it.2013.07.003.
|
[5] |
Chen L,Lu Y,Wang F,et al.Expression of co-stimulatory molecule B7-H4 in patients suffering from rheumatoid arthritis[J].Immunol Lett,2013,154(1/2):25-30.
|
[6] |
Carreno BM,Collins M.BTLA:a new inhibitory receptor with a B7-like ligand[J].Trends Immunol.2003,24(10):524-527.
|
[7] |
Wang S,Chen L.Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses[J].Microbes Infect,2004,6(8):759-766.
|
[8] |
Choi IH, Zhu G, Sica GL, et al. Genomic organization and expression analysis of B7-H4,an immune inhibitory molecule of the B7 family[J].J Immunol,2003,171(9):4 650-4 654.
|
[9] |
Hirotsune S,Yoshida N,Chen A,et al.An expressed pesudogene regulates the messenger-RNA stability of its homologous coding gene[J].Nature,2003,423(6 935):91-96.
|
[10] |
Zhu J,Chu BF,Yang YP,et al.B7-H4 expression is associated with cancer progression and predicts patient survival in human thyroid cancer[J].Asian Pac J Cancer Prev,2013,14(5):3 011-3 015.
|
[11] |
Qian Y,Hong B,Shen L,et al.B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells[J].Cell Tissue Res,2013,353(1):139-151.
|
[12] |
Krambeck AE,Thompson RH,Dong H,et al.B7-H4 expression in renal cell carcinorna and tumor vasculature:associations with cancer progression and survival[J].Proc Natl Acad Sci U S A,2006,103(27):10 391-10 396.
|
[13] |
Simon I,Zhou S,Corral L,et al.B7-H4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer[J].Cancer Res,2006,66(3):1 570-1 575.
|
[14] |
Li ZY,Zhang XH,Chen Y,et al.Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors[J].Oncol Targets Ther,2013,6:869-875.
|
[15] |
Arigami T,Uenosono Y,Ishigami S,et al.Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer[J].World J Surg,2011,35(9):2 051-2 057.
|
[16] |
Jiang J,Zhu Y,Wu C,et al.Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer[J].Cancer Immunol Immunother,2010,59(11):1 707-1 714.
|
[17] |
Quandt D,Fiedler E,Boettcher D,et al.B7-H4 expression in human melanoma:its association with patients′ survival and antitumor immune response[J].Clin Cancer Res,2011,17(10):3 100-3 111.
|
[18] |
Topalian SL,Hodi FS,Brahmer JR,et al.Safety,activity,and immune correlates of anti-PD-1 antibody in cancer[J].N Engl J Med,2012,366(26):2 443-2 454.
|
[19] |
Brahmer JR,Tykodi SS,Chow LQ,et al.Safety and activity of anti-PD-L1 antibody in patients with advanced cancer[J].N Engl J Med,2012,366(26):2 455-2 465.
|
[20] |
Dangaj D,Lanitis E,Zhao A,et al.Novel recombinant human B7-H4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses[J].Cancer Res,2013,73(15):4 820-4 829.
|
[21] |
Zhang L,Wu H,Lu D,et al.The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus[J].Oncogene,2013,doi: 10.1038/onc.2012.600.
|
[22] |
Kryczek I,Wei S,Zou L,et al.Cutting edge:induction of B7-H4 on APCs through IL-10:novel suppressive mode for regulatory T cells[J].J Immunol,2006,177(1):40-44.
|